NCT03450122 2023-10-16Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent SarcomaM.D. Anderson Cancer CenterPhase 1 Completed15 enrolled